Dramatic effects of a new antimicrobial stewardship program in a rural community hospital

American Journal of Infection Control
Claudia R LibertinJoy H Peterson

Abstract

New Joint Commission antimicrobial stewardship requirements took effect on January 1, 2017, promoted as a central strategy for coping with the emerging problems of antimicrobial resistance and Clostridium difficile infection. Our objective was to measure the effects of a new antimicrobial stewardship program (ASP) in a rural community hospital with no prior ASP, in the context of having a new infectious disease specialist on staff. An ASP team was formed to implement a prospective audit with health care provider feedback and targeting 12 antimicrobial agents in a rural hospital in Georgia. An educational grand rounds lecture series was provided before implementation of the ASP to all prescribers. After implementation, algorithms to aid the selection of empirical antibiotics for specific infectious disease syndromes based on local antibiograms were provided to prescribers to improve this selection. Rates of C difficile infections, total targeted antimicrobial costs, and drug utilization rates were calculated for 1 year pre-ASP implementation (2013) and 1 year post-ASP implementation (October 2014-December 2015). The patient safety metric of C difficile infections decreased from 3.35 cases per 1,000 occupied bed days (OBDs) in 20...Continue Reading

Citations

Oct 6, 2017·Expert Review of Anti-infective Therapy·Maria Adriana CataldoNicola Petrosillo
May 24, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edward StenehjemAndrew T Pavia
Aug 17, 2019·JAMA Network Open·Deverick J AndersonUNKNOWN Antibacterial Resistance Leadership Group (ARLG)
Feb 28, 2020·Clinical Microbiology Reviews·Olivier VandenbergAlex van Belkum
Mar 20, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Joshua KnightJenna Swindler
Feb 6, 2020·Infectious Disease Clinics of North America·Evan D RobinsonRobert G Sawyer
Mar 9, 2021·Journal of Pharmacy & Bioallied Sciences·Ovais Ullah ShiraziChe Suraya Zin
Mar 22, 2021·Infection, Disease & Health·Jarrod de JongDanny Tsai
Aug 22, 2018·The Medical Clinics of North America·Whitney R BuckelEdward Stenehjem

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

© 2022 Meta ULC. All rights reserved